Medical Instruments & Equipment Archives - Page 4 of 4

OraSure Technologies Inc. Grows Bottom Line

OraSure Technologies Inc. (NASDAQ:$OSUR) has been consistently raising its bottom line over the past few years, and here’s how: OraSure Technologies’ most recent bottom line was $31 million. That alone has risen substantially since last ... [Read]

The Reason Behind OraSure’s Sudden Stock Rise

Nov 21 Samara Malkin

As of 3:42 p.m. EST Tuesday, OraSure Technologies (NASDAQ:$OSUR) is up 18.6%. This increase occurred after the company announced it had entered into a $143 million agreement for supplying its Oragene devices to an undisclosed ... [Read]

Zacks Investment Research Upgrades VBI Vaccines, Inc. to ‘Hold’

Oct 20 Dylan Bernhardt

A report on Tuesday from Zacks Investment Research upgraded VBI Vaccines (NASDAQ:$VBIV), Inc from a ‘Sell’ to a ‘Hold’ rating. VBI Vaccines is a biotechnology company that specializes in developing vaccines and antigens for issues ... [Read]

52-Week High Broken By OraSure

Oct 20 Dylan Bernhardt

During trading yesterday, stocks of OraSure Technologies Inc. (NASDAQ:$OSUR) set a new 52-week high when it hit prices of $23.01. Shares that day opened at $22.90 and closed at $22.78, representing a change of 0.04%. The ... [Read]

OraSure Technologies, Inc.: What’s Analysts Verdict?

Oct 3 Dylan Bernhardt

According to Zacks, OraSure Technologies, Inc. (NASDAQ:$OSUR) currently has an ABR rank of 73 and a current Average Broker Rating of 1.5. Zacks also says that the number is based on 4 sell-side firms. The ... [Read]

Forecasts Predict $40.82 Million in Sales from OraSure Technologies, Inc.

Sep 26 Dylan Bernhardt

Zacks Investment Research reports that OraSure Technologies, Inc. (NASDAQ:$OSUR) is expected to post sales of $40.82 for the current quarter. This is based on two expert estimates that range from $40.50 million to $41.4 million. ... [Read]

Stock Rating for OraSure Technologies, Inc. lowered by Zacks Investment Research

Sep 25 Dylan Bernhardt

On Tuesday, Zacks Investment Research downgraded OraSure Technologies, Inc (NASDAQ:$OSUR) from a ‘Buy’ rating to a ‘Hold’ rating. OraSure Technologies is a diagnostic company who specializes in using patient’s oral fluid to diagnose a range ... [Read]

Zacks Investment Research Upgrades OraSure Technologies Stock Rating

Sep 20 Dylan Bernhardt

Zacks Investment Research upgraded OraSure Technologies’ (NASDAQ:$OSUR) rating from ‘Hold’ to ‘Buy’. The firm also recommended a target price of $25.00, which is a 14.63% upside from the previous close. OSUR is a medical instrument ... [Read]

Cantor Fitzgerald Global Healthcare Conference to Feature Presentation from OraSure Technologies

Sep 20 Dylan Bernhardt

OraSure Technologies (NASDAQ:$OSUR) announced today that their president and CEO, Douglas A. Michels will speak at the Cantor Fitzgerald Global Healthcare Conference for 2017. Mr. Michels will speak on September 26 at approximately 11:15 AM ... [Read]